BCS and IVIVC Based Biowaivers

Biopharmaceutics Classification System (BCS) and In Vitro-In Vivo Correlation (IVIVC) are regulatory frameworks used to assess the biowaivers for generic drug approval. BCS categorizes drugs based on their solubility and permeability, while IVIVC establishes a correlation between in vitro dissolution and in vivo pharmacokinetic profiles.

 

    Related Conference of BCS and IVIVC Based Biowaivers

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    BCS and IVIVC Based Biowaivers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in